All News

AAA Screening in Primary Care: Criteria, Implementation, and Patient Communication
October 13, 2025

Emergency medicine physician Kabiul Haque, MD, discusses USPSTF screening guidelines for abdominal aortic aneurysm.

FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes
October 13, 2025

The sBLA includes data from the phase 3 INHALE-1 study, which showed Afrezza noninferior to MDI insulin. A PDUFA date is set for May 29, 2026.

Kabiul Haque, MD, on Effective Management of Peripheral Arterial Disease in Primary Care
October 13, 2025

Kabiul Haque, MD, a family medicine physician, shares his four-pillar approach to preventing PAD progression.

Low-Dose Aspirin May be Widely Overused for CVD Prevention Based on PREVENT Estimates
October 13, 2025

Based on the PREVENT algorithm's estimates of 10-year ASCVD risk, 4.2 million adults may need to be reevaluated for aspirin discontinuation, authors reported.

GLP-1 RAs Linked to Atypical Uptake on PET-CT Scans, Raising Interpretation Challenges
October 13, 2025

New research reveals GLP-1 receptor agonists may alter PET-CT scan interpretations, highlighting the need for updated guidelines in oncological imaging.

FDA Clears First Blood Test to Rule Out Alzheimer-Related Pathology in Primary Care
October 13, 2025

Roche's Elecsys pTau181 test has a 97.9% negative predictive value to rule out amyloid pathology, which will improve referral decisions and expedite treatment.

WHO: 1 in 6 Common Infections Now Drug-Resistant, AMR Threatens Global Health
October 13, 2025

New global WHO data show escalating resistance in key bacterial pathogens, threatening frontline antibiotics and narrowing treatment options worldwide.

Vaccines, Policy, and the Erosion of Trust: A Conversation with Chuck Vega, MD
October 10, 2025

Vega considers the impact of recent changes in immunization policy on trust not just among patients but among clinicians as well. It all threatens good patient care, he said.

Telemedicine Improves Inhaler Technique, QoL Following Severe Exacerbation of COPD
October 10, 2025

Telemedicine follow-up after hospital discharge for COPD exacerbation was significantly more effective than standard care and received high patient satisfaction scores.

Johnson & Johnson Rolls Out Data From Major Depressive Disorder Portfolio at ECNP
October 10, 2025

Clinical and real-world data are on deck for lumateperone, seltorexant, and esketamine to treat major depressive disorder and treatment-resistant depression.